Alcon ends macular degeneration drug program
Friday, July 11, 2008 - 18:14
in Health & Medicine
LOS ANGELES (Reuters) - Alcon Inc said on Friday that it has ended development of anecortave acetate as a treatment for lowering the risk of a sight-threatening eye disease known as age-related macular degeneration.